BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12676778)

  • 21. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
    Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
    Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
    Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
    Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia.
    Sugimori C; Chuhjo T; Feng X; Yamazaki H; Takami A; Teramura M; Mizoguchi H; Omine M; Nakao S
    Blood; 2006 Feb; 107(4):1308-14. PubMed ID: 16179371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
    Fattizzo B; Ireland R; Dunlop A; Yallop D; Kassam S; Large J; Gandhi S; Muus P; Manogaran C; Sanchez K; Consonni D; Barcellini W; Mufti GJ; Marsh JCW; Kulasekararaj AG
    Leukemia; 2021 Nov; 35(11):3223-3231. PubMed ID: 33664463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of CD55- and CD59-deficient granulocytic populations in patients with myelodysplastic syndrome.
    Kaiafa G; Papadopoulos A; Ntaios G; Saouli Z; Savopoulos C; Tsesmeli N; Kontoninas Z; Chatzinikolaou A; Tsavdaridou V; Klonizakis I; Hatzitolios A
    Ann Hematol; 2008 Apr; 87(4):257-62. PubMed ID: 18158579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link.
    Griscelli-Bennaceur A; Gluckman E; Scrobohaci ML; Jonveaux P; Vu T; Bazarbachi A; Carosella ED; Sigaux F; SociƩ G
    Blood; 1995 Mar; 85(5):1354-63. PubMed ID: 7858265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive telomere shortening in aplastic anemia.
    Ball SE; Gibson FM; Rizzo S; Tooze JA; Marsh JC; Gordon-Smith EC
    Blood; 1998 May; 91(10):3582-92. PubMed ID: 9572992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones.
    Park SH; Jeong J; Lee SH; Yoo DW; Choi Y; Jo JC; Lim JH
    Ann Lab Med; 2019 Mar; 39(2):150-157. PubMed ID: 30430777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.
    Li Y; Li X; Ge M; Shi J; Qian L; Zheng Y; Wang J
    Ann Hematol; 2011 May; 90(5):529-37. PubMed ID: 21207031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia.
    Pu JJ; Mukhina G; Wang H; Savage WJ; Brodsky RA
    Eur J Haematol; 2011 Jul; 87(1):37-45. PubMed ID: 21447004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for paroxysmal nocturnal hemoglobinuria (PNH) clone in Egyptian children with aplastic anemia.
    Rizk S; Ibrahim IY; Mansour IM; Kandil D
    J Trop Pediatr; 2002 Jun; 48(3):132-7. PubMed ID: 12164595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
    Maciejewski JP; Risitano A; Sloand EM; Nunez O; Young NS
    Blood; 2002 May; 99(9):3129-35. PubMed ID: 11964274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria.
    Kinoshita T; Inoue N
    Int J Hematol; 2002 Feb; 75(2):117-22. PubMed ID: 11939256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
    Feng X; Chuhjo T; Sugimori C; Kotani T; Lu X; Takami A; Takamatsu H; Yamazaki H; Nakao S
    Blood; 2004 Oct; 104(8):2425-31. PubMed ID: 15217832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal dynamics of hematopoietic stem cell compartment in aplastic anemia.
    Visconte V; Maciejewski JP
    Semin Hematol; 2022 Jan; 59(1):47-53. PubMed ID: 35491059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes.
    Iwanaga M; Furukawa K; Amenomori T; Mori H; Nakamura H; Fuchigami K; Kamihira S; Nakakuma H; Tomonaga M
    Br J Haematol; 1998 Jul; 102(2):465-74. PubMed ID: 9695961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution patterns of paroxysmal nocturnal hemoglobinuria clone and clinical implications in acquired bone marrow failure.
    Lian Y; Shi J; Nie N; Huang Z; Shao Y; Zhang J; Huang J; Li X; Ge M; Jin P; Wang M; Zheng Y
    Exp Hematol; 2019 Sep; 77():41-50. PubMed ID: 31472171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome.
    Okamoto M; Shichishima T; Noji H; Ikeda K; Nakamura A; Akutsu K; Maruyama Y
    Leukemia; 2006 Apr; 20(4):627-34. PubMed ID: 16467865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.
    Dunn DE; Tanawattanacharoen P; Boccuni P; Nagakura S; Green SW; Kirby MR; Kumar MS; Rosenfeld S; Young NS
    Ann Intern Med; 1999 Sep; 131(6):401-8. PubMed ID: 10498555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.